These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17998321)

  • 1. Ursodeoxycholic acid in chronic hepatitis C.
    Poupon R; Serfaty L
    Gut; 2007 Dec; 56(12):1652-3. PubMed ID: 17998321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [General therapy of type C chronic hepatitis: efficacy and limitation of hepatoprotective agents].
    Shiraki K; Takei Y
    Nihon Naika Gakkai Zasshi; 2008 Jan; 97(1):28-35. PubMed ID: 18360963
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic hepatitis C and autoimmune cholangitis: a case study and literature review.
    Sánchez-Pobre P; Gonzalez C; Paz E; Colina F; Castellano G; Muñoz-Yague T; Rodriguez S; Yela C; Alvarez V; Solís-Herruzo J
    Dig Dis Sci; 2002 Jun; 47(6):1224-9. PubMed ID: 12064795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon and ursodeoxycholic acid combined therapy in chronic viral C hepatitis: controlled randomized trial in 203 patients.
    Boucher E; Guyader D; Jacquelinet S; Andre P; Mendler MH; Turlin B; Canva V; Nousbaum JB; Bernard PH; Nouel O; Raabe JJ; Dao T; Gasser P; Verger P; Boutin J; Bergerault P; Joram F; Colmar P; Messner M; Brissot P; Deugnier Y
    Dig Liver Dis; 2000; 32(1):29-33. PubMed ID: 10975752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic hepatitis C with interferon with or without ursodeoxycholic acid: a randomized prospective trial.
    Abdelmalek MF; Harrison ME; Gross JB; Poterucha JJ; Gossard AA; Spivey JR; Rakela J; Lindor KD
    J Clin Gastroenterol; 1998 Mar; 26(2):130-4. PubMed ID: 9563925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study.
    Cadranel JF; Di Martino V; Dorent R; Bernard B; Hoang C; Myara A; Pauwels A; Ghoussoub JJ; Perrin M; Grippon P; Thabut D; Trivin F; Huraux JM; Gandjbakhch I; Opolon P; Lunel F
    Transplantation; 2003 Apr; 75(7):977-82. PubMed ID: 12698083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid for primary biliary cirrhosis: treat early to slow progression.
    Paumgartner G
    J Hepatol; 2003 Jul; 39(1):112-4. PubMed ID: 12821052
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term treatment of chronic hepatitis C with ursodeoxycholic acid: influence of HCV genotypes and severity of liver disease.
    Lirussi F; Beccarello A; Bortolato L; Morselli-Labate AM; Crovatto M; Ceselli S; Santini G; Crepaldi G
    Liver; 1999 Oct; 19(5):381-8. PubMed ID: 10533795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients.
    Tsubota A; Kumada H; Arase Y; Chayama K; Saitoh S; Ikeda K; Kobayashi M; Suzuki Y; Murashima N
    Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1077-83. PubMed ID: 10524635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of alanine aminotransferase by administration of suplatast tosilate plus ursodeoxycholic acid in patients with resistance to ursodeoxycholic acid monotherapy on hepatitis C virus-related chronic liver disease.
    Matsuda Y; Inada M; Maeda H; Matsuyama T
    Intern Med; 2002 Oct; 41(10):774-9. PubMed ID: 12412994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ursodeoxycholic acid in children with prolonged hepatitis A virus infection that may be a trigger factor for autoimmune hepatitis.
    Koçak N; Saltik IN
    Am J Gastroenterol; 2001 Feb; 96(2):610-1. PubMed ID: 11232728
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experience in treatment of chronic toxic hepatitis by ursodeoxicholic acid].
    Agzamova GS
    Med Tr Prom Ekol; 2001; (1):39-42. PubMed ID: 11221110
    [No Abstract]   [Full Text] [Related]  

  • 13. Ursodeoxycholic acid in the management of prolonged cholestasis of acute hepatitis B.
    Kadayifci A; Savas MC; Arslan S; Güllú IH
    J Clin Gastroenterol; 1997 Mar; 24(2):125-6. PubMed ID: 9077736
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-alcoholic steato-hepatitis.
    Chawla Y; Amrapurkar D
    Trop Gastroenterol; 2002; 23(4):186-8. PubMed ID: 12833707
    [No Abstract]   [Full Text] [Related]  

  • 15. Looking Into the Crystal Ball: Predicting Non-response to Ursodeoxycholic Acid in Primary Biliary Cholangitis.
    Zimmer V; Lammert F
    EBioMedicine; 2017 Feb; 15():10-11. PubMed ID: 28007481
    [No Abstract]   [Full Text] [Related]  

  • 16. [The characteristics of the use of ursodeoxycholic acid in chronic diseases of the hepatobiliary system].
    Dehtiar'ova II; Chernenko VV; Anokhina HA; Opanasiuk ND; Pavlik-Novol's'kyĭ T; Haĭsenko AV
    Lik Sprava; 1995; (9-12):47-8. PubMed ID: 8983789
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of autoimmune hepatitis followed-up with an oral administration of ursodeoxycholic acid].
    Sugimoto M; Saito Y; Akimoto T; Kato H; Miyashita M; Shinohara M; Shinohara M; Wakui T; Hirata A; Saito N; Nonaka H
    Nihon Shokakibyo Gakkai Zasshi; 2004 Nov; 101(11):1232-7. PubMed ID: 15570873
    [No Abstract]   [Full Text] [Related]  

  • 18. Ursodeoxycholic acid for terbinafine-induced toxic hepatitis.
    Agca E; Akcay A; Simsek H
    Ann Pharmacother; 2004 Jun; 38(6):1088-9. PubMed ID: 15122001
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis.
    Bécheur H; Dall'osto H; Chatellier G; Charton-Bain MC; Aubertin JM; Attar A; Bloch F; Petite JP
    Dig Dis Sci; 1997 Apr; 42(4):789-91. PubMed ID: 9125650
    [No Abstract]   [Full Text] [Related]  

  • 20. [Peripheral blood lymphocyte apoptosis in children with viral hepatites A, B, C and effect of ursodeoxycholic acid preparations].
    Matanina NV; Reĭzis AR
    Eksp Klin Gastroenterol; 2008; (5):106-10. PubMed ID: 19145924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.